Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.
D000818:Animals; D000906:Antibodies; D002860:Chromium Radioisotopes; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006649:Histocompatibility Antigens / Q000302:isolation & purification; D007106:Immune Sera; D007109:Immunity; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007519:Isoantigens; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000276:immunology; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000906:Antibodies; D002860:Chromium Radioisotopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007519:Isoantigens; D003165:Complement System Proteins